clinical trial · NCT05508594
Efficacy and Pharmacokinetic-Pharmacodynamic Relationship of Intranasally Administered Sufentanil, Ketamine, and CT001
PainCT001PlaceboSufentanilKetamine
brief summary
A randomised, double-blind, parallel-group, study comparing the analgesic effect of intranasal CT001 to intranasal sufentanil, intranasal ketamine or placebo for treatment of acute pain in adults undergoing surgical removal of an impacted mandibular third molar, where bone removal is judged to be needed.
started
Sep 5, 2022
primary completion
Oct 5, 2023
completion
Oct 5, 2023
last updated
Oct 18, 2023
official title
Analgesic Efficacy and Pharmacokinetic-pharmacodynamic Relationship of Intranasally Administered Sufentanil, Ketamine, and CT001 After Impacted Mandibular Third Molar Extraction - A Double-blind, Randomised, Placebo-controlled Study
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol